The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Industry sponsorship and research outcome
Abstract
This is a protocol for a Cochrane Review (Methodology). The objectives are as follows: The objectives are to investigate whether: funding of drug studies by the pharmaceutical industry is associated with outcomes that are favorable to the funder; drug studies funded by the pharmaceutical industry differ in their risk of bias compared with studies with other sources of support; funding of device studies by the device industry is associated with outcomes that are favorable to the funder; and device studies funded by the device industry differ in their risk of bias compared with studies with other sources of support.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147
Self-citationScope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman, J. E., Li, Y., & Gross, C. P. (2003) · JAMA · doi:10.1001/jama.289.4.454 · Cited by 1,816
Research works printed but not linked: 10
- Anderson, 1991, Secular changes in published clinical trials of second-line agents in rheumatoid arthritis, Arthritis and Rheumatism, 34, 1304, 10.1002/art.1780341015 · DOI
- Anis, 2000, Using economic evaluations to make formulary coverage decisions: so much for guidelines, Pharmacoeconomics, 18, 55, 10.2165/00019053-200018010-00006 · DOI
- Bero, 1996, Influences on the quality of published drug studies, International Journal of Technology Assessment in Health Care, 12, 209, 10.1017/S0266462300009582 · DOI · Paper page
- Dorman, 1999, Report of randomized trials in acute stroke, 1955 to 1995: what proportions were commercially sponsored?, Stroke, 30, 1995, 10.1161/01.STR.30.10.1995 · DOI
- Hill, 2000, Problems with the interpretation of pharmacoeconomic analyses: a review of submissions to the Australian pharmaceutical benefits scheme, JAMA, 283, 2116, 10.1001/jama.283.16.2116 · DOI · Paper page
- Karlberg, 2008, West to east drift in European sponsored clinical trials, Clinical Trials Magnifier, 1, 101
- The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011
- Sismondo, 2008, How pharmaceutical industry funding affects trial outcomes: casual structures and responses, Social Science and Medicine, 66, 1909, 10.1016/j.socscimed.2008.01.010 · DOI · Paper page
- Steinman, 2006, The promotion of gabapentin: an analysis of internal industry documents, Annals of Internal Medicine, 145, 284, 10.7326/0003-4819-145-4-200608150-00008 · DOI · Paper page
- Wyatt, 1991, Use and sources of medical knowledge, Lancet, 338, 1368, 10.1016/0140-6736(91)92245-W · DOI · Paper page
Cited by
Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A., & the PRISMA-P Group (2015) · BMJ · doi:10.1136/bmj.g7647 · Cited by 13,120
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
Self-citationMargulis, A. V., Pladevall, M., Riera-Guardia, N., Varas-Lorenzo, C., Hazell, L., Berkman, N., Viswanathan, M., & Perez-Gutthann, S. (2014) · Clinical Epidemiology · doi:10.2147/clep.s66677 · Cited by 441
Agache, I., Beltran, J., Akdis, C., Akdis, M., Canelo‐Aybar, C., Canonica, G. W., Casale, T., Chivato, T., Corren, J., Del Giacco, S., et al. (2020) · Allergy · doi:10.1111/all.14221 · Cited by 408
Risk of bias in reports of in vivo research: a focus for improvement
Macleod, M. R., Lawson McLean, A., Kyriakopoulou, A., Serghiou, S., de Wilde, A., Sherratt, N., Hirst, T., Hemblade, R., Bahor, Z., Nunes-Fonseca, C., et al. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002273 · Cited by 358
Metadata
- Authors
- Lundh, A., Lexchin, J., Sismondo, S., Busuioc, O. A., & Bero, L.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2011-09-07
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W4243221823
- Cited by
- 166
- References
- 2
- Type
- reference entry
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Industry sponsorship and research outcome. https://app.cochat.ai/papers/10.1002/14651858.mr000033
- The paper
- Lundh, A., Lexchin, J., Sismondo, S., Busuioc, O. A., & Bero, L. (2011). Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.mr000033
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.